Moderna reports positive results in head and neck cancer
PARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
Read morePARIS - Moderna shares rose 8 per cent to a three-month high after the company's individualized cancer vaccine developed with ...
Read moreNEW YORK ― Moderna said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower ...
Read moreNEW YORK - US drugmaker Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot targeting ...
Read moreNEW YORK - An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17. Advisers to ...
Read moreNEW YORK - Kids ages 5 to 11 should get a booster dose of Pfizer´s COVID-19 vaccine, advisers to the ...
Read moreWASHINGTON - COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter. The vaccine maker said ...
Read moreWASHINGTON - Moderna Inc's chief medical officer said the company's vaccine for children under 6 years old will be ready ...
Read moreLONDON - AstraZeneca's COVID-19 vaccine still has a role to play in the fight against the pandemic, even as sales ...
Read moreNEW YORK - Moderna’s Covid-19 vaccine works in babies, toddlers and preschoolers, the company announced Wednesday - and if regulators ...
Read moreNEW YORK - The Centers for Disease Control and Prevention continued its endorsement of Moderna's COVID-19 vaccine for adults, now ...
Read moreWould you like to receive notifications on our latest news ?
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.
© 2021 All Rights Reserved for Egyptian Gazette - Admined by Digital Transformation Management.